T3876 |
Loureirin B
|
119425-90-0
|
98%
|
|
Loureirin B can downregulate the expression of fibrosis-related molecules by regulating MMPs and TIMPs levels, inhibit scar fibroblast proliferation and suppress...
|
T4S0592 |
Toddalolactone
|
483-90-9
|
98%
|
|
anti-inflammatory and analgesic.
|
T4255 |
TM5275 sodium
|
1103926-82-4
|
98%
|
|
TM5275 is an inhibitor of plasminogen activator inhibitor 1 (PAI-1).
|
T9947 |
GW-6604
|
452342-37-9
|
98%
|
|
GW-6604 is an ALK5 inhibitor and shows clear antifibrotic effects resulting in liver function improvement.
|
T4254 |
TM5441
|
1190221-43-2
|
98%
|
|
TM5441 is an orally bioavailable inhibitor of plasminogen activator inhibitor 1 (PAI-1).
|
T13257 |
Upamostat
|
590368-25-5
|
98%
|
|
Upamostat is an inhibitor of a serine protease and is a urokinase plasminogen activator (uPA) inhibitor.
|
T23764 |
AZ3976
|
1418747-15-5
|
98%
|
|
AZ3976 is an inhibitor of PAI-1 with an IC50 of 16 μM in a plasma clot lysis assay. AZ3976 displays profibrinolytic activities.
|
T29856 |
Aleplasinin
|
481629-87-2
|
98%
|
|
Aleplasinin is a selective and orally active inhibitor of Plasminogen activator inhibitor-1(PAI-1) and a key negative regulator of the fibrinolytic system. Alepl...
|
T8962 |
TM5007
|
342595-05-5
|
98%
|
|
TM5007 is a poent inhibitor of plasminogen activator inhibitor-1 (PAI-1; IC50 of 29 uM).
|
T3442 |
UK-371804
|
256477-09-5
|
98%
|
|
UK-371804 is an effective and specific uPA inhibitor. It was selected as a candidate for further preClinicalal evaluation for the treatment of chronic dermal ulc...
|
T26629 |
Angstrom6
|
220334-14-5
|
98%
|
|
Angstrom6 is an 8 amino acid peptide derived from single chain urokinase fibrinogen activator (scuPA) that interferes with the uPA/uPAR cascade and abrogates the...
|
T2030 |
Tiplaxtinin
|
393105-53-8
|
98%
|
|
Tiplaxtinin(PAI-039) is a selective and orally efficacious inhibitor of plasminogen activator inhibitor-1 (PAI-1) with IC50 of 2.7 uM.
|